Evaluation of the U.S. Marshals Service’s Pharmaceutical Drug Costs and Procurement Process

Submitting OIG:

Date Issued:

Wednesday, December 21, 2022

Agency Reviewed / Investigated:

Submitting OIG-Specific Report Number:

23-014

Component, if applicable:

United States Marshals Service

Location(s):

Agency-Wide

Type of Report:

Inspection / Evaluation

Questioned Costs:

Funds for Better Use:

View Document:

Attachment	Size
23-014.pdf	2.54 MB

Related Open Recommendations

Recommendation Number	Recommendation Status	Significant Recommendation	Additional Details
1	Open	No	https://oig.justice.gov/reports
Conduct additional market research to test the existing assumption that combining Pharmacy Program and non-Pharmacy Program tasks into one contract is the most cost-effective method to provide quality healthcare to USMS detainees.
3	Open	No	https://oig.justice.gov/reports
Consider implementing a process by which it could proactively advise on the procurement of high-priced drugs before such drugs are purchased by non-Pharmacy Program intergovernmental agreement facilities.